| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5883496 | Journal of Cardiothoracic and Vascular Anesthesia | 2016 | 7 Pages |
Abstract
The antifibrinolytic, EACA, was not associated with an increased incidence of thromboembolic complications or postoperative acute kidney injury, and it did not alter 1-year survival after liver transplantation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ramona MD, PhD, Timothy C. MD, Donald R. MD, Brian M. MD, Joseph MD, William J. MD, Brian MD, Ari J. MD, MSc, FRCSC, FACS, Trevor W. MD, PhD, Humberto E. MD, FACS, David S. MD, Ian C. MD, George E. MD, FACS, PhD, Marina MD, Thomas MD, Bobby D. MD,